• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外生性(带蒂)恶性黑色素瘤——克利夫兰诊所的经验

Exophytic (pedunculated) malignant melanoma--Cleveland Clinic experience.

作者信息

Siminovitch J M, Bergfeld W, Dinner M

出版信息

Ann Plast Surg. 1980 Dec;5(6):432-5.

PMID:7469322
Abstract

Since few cases of exophytic malignant melanoma have been reported, their nature, history, and prognosis have been uncertain and controversial. We report 26 cases followed at the Cleveland Clinic from 1969 to 1975. Twenty men and 6 women ranging in age from 19 to 65 years were followed. There were 16 deaths, 3 patients are alive with lymph node metastases, and 3 patients are alive with distant metastases, for a 2-year disease-free survival of 15% and 5-year survival of 33%. All patients had lesions of either Clark level III, IV, or V with no correlation to survival. All lesions were 2 mm or more in thickness. A 44% disease-free survival was found for lesions 2 to 3 mm in thickness and no disease-free survival for lesions thicker than 3 mm. Our findings support the concept that exophytic malignant melanomas have increased malignant potential. We believe all malignant melanomas should be classified according to both Clark levels and Breslow's micrometer thickness measurements.

摘要

由于外生性恶性黑色素瘤的病例报告较少,其性质、病程及预后一直不明确且存在争议。我们报告了1969年至1975年在克利夫兰诊所随访的26例病例。随访了年龄在19岁至65岁之间的20名男性和6名女性。有16例死亡,3例患者存活但有淋巴结转移,3例患者存活但有远处转移,2年无病生存率为15%,5年生存率为33%。所有患者的病变均为克拉克三级、四级或五级,与生存率无关。所有病变厚度均在2毫米或以上。厚度为2至3毫米的病变无病生存率为44%,厚度超过3毫米的病变无病生存率为零。我们的研究结果支持外生性恶性黑色素瘤具有更高恶性潜能这一概念。我们认为所有恶性黑色素瘤都应根据克拉克分级和布雷斯洛微米厚度测量进行分类。

相似文献

1
Exophytic (pedunculated) malignant melanoma--Cleveland Clinic experience.外生性(带蒂)恶性黑色素瘤——克利夫兰诊所的经验
Ann Plast Surg. 1980 Dec;5(6):432-5.
2
Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?T1期(薄型)黑色素瘤的前哨淋巴结活检:有必要吗?
Ann Plast Surg. 2003 Jun;50(6):601-6. doi: 10.1097/01.SAP.0000069065.00486.1E.
3
Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.前哨淋巴结微转移及其他组织学因素对较厚黑色素瘤患者预后的预测作用
J Am Acad Dermatol. 2001 May;44(5):762-6. doi: 10.1067/mjd.2001.112346.
4
Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.高危薄型黑色素瘤的识别应基于 Breslow 深度而非 Clark 四级。
Cancer. 2001 Mar 1;91(5):983-91.
5
Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.黑色素瘤中的 Breslow 厚度和 Clark 分级:支持在病理报告及美国癌症联合委员会分期中纳入分级。
Cancer. 2000 Feb 1;88(3):589-95.
6
Malignant melanoma in Turkey: a single institution's experience on 475 cases.土耳其的恶性黑色素瘤:一家机构对475例病例的经验。
Jpn J Clin Oncol. 2006 Dec;36(12):794-9. doi: 10.1093/jjco/hyl114. Epub 2006 Oct 23.
7
[Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].[前哨淋巴结活检对恶性黑色素瘤患者的重要预后意义]
Ned Tijdschr Geneeskd. 2004 May 1;148(18):884-8.
8
[Survival analysis in patients with cutaneous malignant melanoma].[皮肤恶性黑色素瘤患者的生存分析]
Srp Arh Celok Lek. 1997 May-Jun;125(5-6):132-7.
9
Cutaneous melanomas that defy conventional prognostic indicators.对传统预后指标无反应的皮肤黑色素瘤。
Semin Oncol. 1996 Dec;23(6):709-13.
10
Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.影响薄皮黑色素瘤预后的病理和临床特征:与新提出的分期系统的相关性
Am Surg. 2000 Jun;66(6):527-31; discussion 531-2.

引用本文的文献

1
Giant cutaneous melanomas: evidence for primary tumour induced dormancy in metastatic sites?巨大皮肤黑色素瘤:转移部位存在原发性肿瘤诱导休眠的证据?
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2009.2073. Epub 2009 Oct 5.